ArticleFrontiers in pediatrics2025
Pathogen distribution, antimicrobial resistance and attributable cost analysis of neonatal sepsis in neonatal intensive care units: a propensity score matching study.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Microbial etiology and antimicrobial resistance patterns in neonates admitted to a tertiary neonatal intensive care unit in Mogadishu, Somalia.Frontiers in pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Neonatal sepsis (NS) is a serious infection in neonatal intensive care units (NICUs) that treatment challenges due to evolving antimicrobial resistance and a substantial healthcare burden. The aim of this study was to analyze the pathogenic characteristics of NS in Chinese NICUs and its independent impact on length of stay (LOS) and hospitalization costs. Methods: A retrospective case-control study was conducted including 978 neonates from two tertiary NICUs between July 1, 2023, and June 30, 2024. Propensity score matching (PSM) was used to balance the baseline characteristics between the NS and non-NS groups. Generalized linear models (GLM) were used to quantify the LOS and hospitalization costs attributable to NS. Pathogen distribution and antimicrobial resistance patterns were also assessed. Results: The incidence of NS was 8.28%. The predominant pathogens of NS were Gram-positive bacteria (71.7%), with Conclusions: NS significantly increases the hospitalization resource consumption in NICUs. This study provides key evidence for optimizing antibiotic use strategies and advancing precision healthcare payment reform, and calls for integrating resistance surveillance with cost-control measures to reduce the health economic impact of NS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.